Chimeric antigen receptor natural killer (CAR-NK) cell design and engineering for cancer therapy.

Gong Y, Klein Wolterink RGJ, Wang J, Bos GMJ, Germeraad WTV.

Open source

DOI: 10.1186/s13045-021-01083-5
Published: 2021-05-01
Container: J Hematol Oncol
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s13045-021-01083-5,
  title = {Chimeric antigen receptor natural killer (CAR-NK) cell design and engineering for cancer therapy.},
  author = {Gong Y and  Klein Wolterink RGJ and  Wang J and  Bos GMJ and  Germeraad WTV.},
  year = {2021},
  journal = {J Hematol Oncol},
  doi = {10.1186/s13045-021-01083-5},
  url = {https://doi.org/10.1186/s13045-021-01083-5}
}

RIS

TY  - JOUR
TI  - Chimeric antigen receptor natural killer (CAR-NK) cell design and engineering for cancer therapy.
AU  - Gong Y
AU  -  Klein Wolterink RGJ
AU  -  Wang J
AU  -  Bos GMJ
AU  -  Germeraad WTV.
PY  - 2021
JO  - J Hematol Oncol
DO  - 10.1186/s13045-021-01083-5
UR  - https://doi.org/10.1186/s13045-021-01083-5
ER  -

APA

Y, G., RGJ, K. W., J, W., GMJ, B., & WTV., G. (2021). Chimeric antigen receptor natural killer (CAR-NK) cell design and engineering for cancer therapy.. J Hematol Oncol. https://doi.org/10.1186/s13045-021-01083-5

Source records

europe-pmc · retrieved 2026-09-27T02:55:38.047Z
doaj · retrieved 2026-09-27T02:55:38.071Z